Symbols / SGP Stock $23.21 -4.37% SpyGlass Pharma, Inc.

Healthcare • Biotechnology • United States • NMS
SGP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Patrick H. Mooney
Exch · Country NMS · United States
Market Cap 775.83M
Enterprise Value 526.57M
Income -44.86M
Sales —
FCF (ttm) —
Book/sh -44.85
Cash/sh 7.51
Employees 65
Insider 10d —
IPO Feb 06, 2026
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -8.98
PEG —
P/S —
P/B -0.52
P/C —
EV/EBITDA -10.80
EV/Sales —
Quick Ratio 37.75
Current Ratio 38.00
Debt/Eq 0.64
LT Debt/Eq —
EPS (ttm) -1.25
EPS next Y -2.58
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-13
Earnings (prior) 2026-05-14
ROA —
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 33.43M
Shs Float 6.48M
Insider Own 42.83%
Instit Own 93.53%
Short Float 7.98%
Short Ratio 11.80
Short Interest 884.60K
52W High 32.44
vs 52W High -28.45%
52W Low 20.15
vs 52W Low 15.19%
Beta —
Impl. Vol. —
Rel Volume 0.34
Avg Volume 101.98K
Volume 34.91K
Target (mean) $45.00
Tgt Median $42.00
Tgt Low $37.00
Tgt High $62.00
# Analysts 5
Recom None
Prev Close $24.27
Price $23.21
Change -4.37%
About

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was incorporated in 2019 and is based in Aliso Viejo, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$45.00
Mean price target
2. Current target
$23.21
Latest analyst target
3. DCF / Fair value
$45.00
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
$23.21
Low
$37.00
High
$62.00
Mean
$45.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-10 init HC Wainwright & Co. — → Buy $37
2026-03-03 init Citigroup — → Buy $42
2026-03-03 init Leerink Partners — → Outperform $42
2026-03-03 init Jefferies — → Buy $62
2026-03-03 init Stifel — → Buy $42
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
Operating Expense
41.45
+53.15%
27.06
+90.18%
14.23
Research And Development
29.18
+46.03%
19.98
+100.65%
9.96
Selling General And Administration
12.27
+73.25%
7.08
+65.78%
4.27
General And Administrative Expense
12.27
+73.25%
7.08
+65.78%
4.27
Other Gand A
12.27
+73.25%
7.08
+65.78%
4.27
Total Expenses
41.45
+53.15%
27.06
+90.18%
14.23
Operating Income
-41.45
-53.15%
-27.06
-90.18%
-14.23
Total Operating Income As Reported
-41.45
-53.15%
-27.06
-90.18%
-14.23
EBITDA
-40.84
-52.42%
-26.79
-89.92%
-14.11
Normalized EBITDA
-40.84
-52.42%
-26.79
-89.92%
-14.11
Reconciled Depreciation
0.61
+125.83%
0.27
+120.92%
0.12
EBIT
-41.45
-53.15%
-27.06
-90.18%
-14.23
Net Income
-39.87
-36.71%
-29.16
-118.97%
-13.32
Pretax Income
-39.87
-36.71%
-29.16
-118.97%
-13.32
Net Non Operating Interest Income Expense
3.11
+135.84%
1.32
+44.51%
0.91
Net Interest Income
3.11
+135.84%
1.32
+44.51%
0.91
Interest Income Non Operating
3.11
+135.84%
1.32
+44.51%
0.91
Interest Income
3.11
+135.84%
1.32
+44.51%
0.91
Other Income Expense
-1.53
+55.34%
-3.42
—
Other Non Operating Income Expenses
-1.53
+55.34%
-3.42
—
Tax Provision
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-39.87
-36.71%
-29.16
-118.97%
-13.32
Net Income From Continuing Operation Net Minority Interest
-39.87
-36.71%
-29.16
-118.97%
-13.32
Net Income From Continuing And Discontinued Operation
-39.87
-36.71%
-29.16
-118.97%
-13.32
Net Income Continuous Operations
-39.87
-36.71%
-29.16
-118.97%
-13.32
Normalized Income
-39.87
-36.71%
-29.16
-118.97%
-13.32
Net Income Common Stockholders
-39.87
-36.71%
-29.16
-118.97%
-13.32
Diluted EPS
—
-1.62
-38.99%
-1.17
Basic EPS
—
-1.62
-38.99%
-1.17
Basic Average Shares
—
17.96
+57.55%
11.40
Diluted Average Shares
—
17.96
+57.55%
11.40
Diluted NI Availto Com Stockholders
-39.87
-36.71%
-29.16
-118.97%
-13.32
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
115.87
+396.90%
23.32
-43.33%
41.15
Current Assets
108.77
+524.89%
17.41
-57.14%
40.61
Cash Cash Equivalents And Short Term Investments
107.44
+560.41%
16.27
-59.65%
40.32
Cash And Cash Equivalents
96.36
+492.32%
16.27
+2.65%
15.85
Other Short Term Investments
11.08
0.00
-100.00%
24.47
Receivables
0.43
+1.89%
0.42
+244.17%
0.12
Other Receivables
0.43
+1.89%
0.42
+244.17%
0.12
Prepaid Assets
0.90
+26.01%
0.71
+307.46%
0.18
Other Current Assets
—
0.23
—
Total Non Current Assets
7.10
+20.06%
5.91
+1005.86%
0.53
Net PPE
3.89
-28.72%
5.46
+1117.19%
0.45
Gross PPE
5.00
-16.61%
6.00
+733.97%
0.72
Accumulated Depreciation
-1.11
-105.16%
-0.54
-100.22%
-0.27
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
2.40
+14.94%
2.09
+190.43%
0.72
Construction In Progress
0.43
0.00
—
Other Properties
1.55
-52.84%
3.29
—
Leases
0.62
+0.00%
0.62
+148703.83%
0.00
Non Current Deferred Assets
2.71
0.00
—
Other Non Current Assets
0.49
+8.61%
0.45
+426.03%
0.09
Total Liabilities Net Minority Interest
214.70
+156.23%
83.79
+13.03%
74.13
Current Liabilities
8.58
+10.18%
7.79
+390.41%
1.59
Payables And Accrued Expenses
2.70
+36.30%
1.98
+209.47%
0.64
Payables
2.70
+36.30%
1.98
+209.47%
0.64
Accounts Payable
2.70
+36.30%
1.98
+209.47%
0.64
Pensionand Other Post Retirement Benefit Plans Current
2.18
+70.20%
1.28
+110.51%
0.61
Current Debt And Capital Lease Obligation
—
0.44
—
Current Capital Lease Obligation
0.00
-100.00%
0.44
0.00
Other Current Liabilities
3.71
-9.37%
4.09
+1100.90%
0.34
Total Non Current Liabilities Net Minority Interest
206.12
+171.21%
76.00
+4.76%
72.55
Long Term Debt And Capital Lease Obligation
1.58
-54.21%
3.46
0.00
Long Term Capital Lease Obligation
1.58
-54.21%
3.46
0.00
Preferred Securities Outside Stock Equity
204.54
+181.94%
72.55
0.00%
72.55
Stockholders Equity
-98.84
-63.44%
-60.47
-83.34%
-32.99
Common Stock Equity
-98.84
-63.44%
-60.47
-83.34%
-32.99
Capital Stock
0.00
0.00
-100.00%
0.00
Common Stock
0.00
0.00
-100.00%
0.00
Share Issued
31.91
+0.00%
31.91
+0.00%
31.91
Ordinary Shares Number
31.91
+0.00%
31.91
+0.00%
31.91
Additional Paid In Capital
5.89
+34.33%
4.39
+61.76%
2.71
Retained Earnings
-104.73
-61.47%
-64.86
-81.70%
-35.70
Total Equity Gross Minority Interest
-98.84
-63.44%
-60.47
-83.34%
-32.99
Total Capitalization
-98.84
-63.44%
-60.47
-83.34%
-32.99
Working Capital
100.18
+941.96%
9.62
-75.36%
39.03
Invested Capital
-98.84
-63.44%
-60.47
-83.34%
-32.99
Total Debt
1.58
-59.40%
3.90
0.00
Capital Lease Obligations
1.58
-59.40%
3.90
0.00
Net Tangible Assets
-98.84
-63.44%
-60.47
-83.34%
-32.99
Tangible Book Value
-98.84
-63.44%
-60.47
-83.34%
-32.99
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
-32.70
-48.46%
-22.03
-79.41%
-12.28
Cash Flow From Continuing Operating Activities
-32.70
-48.46%
-22.03
-79.41%
-12.28
Net Income From Continuing Operations
-39.87
-36.71%
-29.16
-118.97%
-13.32
Depreciation Amortization Depletion
0.61
+125.83%
0.27
+120.92%
0.12
Depreciation
0.61
+125.83%
0.27
+120.92%
0.12
Depreciation And Amortization
0.61
+125.83%
0.27
+120.92%
0.12
Other Non Cash Items
-0.21
-133.66%
0.62
+1014.53%
-0.07
Stock Based Compensation
2.79
+86.98%
1.49
+70.44%
0.87
Operating Gains Losses
0.01
—
—
Unrealized Gain Loss On Investment Securities
1.53
-55.34%
3.42
0.00
Gain Loss On Sale Of PPE
0.01
0.00
—
Change In Working Capital
2.45
+82.96%
1.34
+1091.48%
0.11
Change In Receivables
-0.01
+97.33%
-0.30
-245.63%
-0.09
Change In Prepaid Assets
-0.19
+65.56%
-0.54
-810.98%
-0.06
Change In Payables And Accrued Expense
3.12
+33.15%
2.34
+427.75%
0.44
Change In Accrued Expense
2.57
+155.92%
1.00
+266.23%
0.27
Change In Payable
0.55
-59.00%
1.34
+688.90%
0.17
Change In Account Payable
0.55
-59.00%
1.34
+688.90%
0.17
Change In Other Current Assets
-0.04
+89.65%
-0.37
-756.66%
-0.04
Change In Other Current Liabilities
-0.44
-319.40%
0.20
+240.62%
-0.14
Investing Cash Flow
-11.79
-152.98%
22.26
+208.66%
-20.49
Cash Flow From Continuing Investing Activities
-11.79
-152.98%
22.26
+208.66%
-20.49
Net PPE Purchase And Sale
-0.79
+60.37%
-1.99
-819.45%
-0.22
Capital Expenditure
-0.79
+60.37%
-1.99
-819.45%
-0.22
Net Investment Purchase And Sale
-11.01
-145.38%
24.25
+219.65%
-20.27
Purchase Of Investment
-17.00
+17.59%
-20.63
+39.39%
-34.04
Sale Of Investment
6.00
-86.64%
44.88
+225.94%
13.77
Financing Cash Flow
124.58
+67243.24%
0.18
-99.53%
39.77
Cash Flow From Continuing Financing Activities
124.58
+67243.24%
0.18
-99.53%
39.77
Net Common Stock Issuance
-1.45
0.00
—
Common Stock Payments
-1.45
0.00
—
Repurchase Of Capital Stock
-1.45
0.00
—
Proceeds From Stock Option Exercised
0.17
-8.11%
0.18
+1753.52%
0.01
Net Other Financing Charges
-1.47
—
-0.25
Changes In Cash
80.09
+19014.56%
0.42
-94.02%
7.01
Beginning Cash Position
16.27
+2.64%
15.85
+79.23%
8.84
End Cash Position
96.36
+492.32%
16.27
+2.65%
15.85
Free Cash Flow
-33.49
-39.44%
-24.02
-92.23%
-12.49
Income Tax Paid Supplemental Data
0.00
-94.44%
0.02
-10.22%
0.02
Issuance Of Capital Stock
127.34
0.00
-100.00%
40.01
Net Preferred Stock Issuance
127.34
0.00
-100.00%
40.01
Preferred Stock Issuance
127.34
0.00
-100.00%
40.01
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category